caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1881607216

John DeysineM.D.

PRACTICESURGICAL ONCOLOGY ASSOCIATESSee all providers at this practice →
General SurgeryBrooklyn, NYI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where John Deysine's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 5 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Charlynn Maniatis
Diagnostic Radiology · Brooklyn, NY
2498
Cblpath, Inc
Clinical Laboratory · Rye Brook, NY
2359
NEW YORK CITY HEALTH AND HOSPITALS CORPORATION2176
Bioreference Health, Llc
Clinical Laboratory · Elmwood Park, NJ
1633
Sunrise Medical Laboratories, Inc.
Clinical Laboratory · Hicksville, NY
1119
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
283
Unique beneficiaries
—
Total services
399
Distinct HCPCS
3
Medicare payment
$43K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 1,366 General Surgery providers in NY — above median (cohort median 254).
QUALITY · MIPS · 2024
Final MIPS score
94.5
Quality
84.7
Cost
71.5
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.82%
Group
PRESCRIBING · PART D · 2024
Total Rx claims
28
Beneficiaries
—
Total drug cost
$259
Distinct drugs
2
Brand share
0.0%
Top prescribed drugs
Anastrozole17 claims
Exemestane11 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.